Study of Patient With Frequent COPD Exacerbations
NCT07221981 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1519
Last updated 2026-04-17
Summary
This Study is a multicenter, non-interventional, observational, ambispective (retrospective-prospective) study to evaluate clinical and demographic characteristics, approaches to therapy in outpatients with COPD and frequent exacerbations in the Russian Federation. Planned number of Study site is 35 outpatient centers with experience of treatment of COPD with frequency exacerbations in about 30 regions in Russia.
Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-12-16
- Primary Completion
- 2026-06-30
- Completion
- 2026-06-30
Countries
- Russia
Study Locations
More Related Trials
-
The Study Will Evaluate the Effect of AZD8683 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT01205269 ·Status: COMPLETED ·Phase: PHASE2
-
Exacerbantes Study
NCT06147206 ·Status: NOT_YET_RECRUITING
-
AZD8683 Multiple Dose Study in Healthy Volunteers and Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT01584739 ·Status: TERMINATED ·Phase: PHASE1
-
Effects of COPD Standardized Management on COPD Exacerbation
NCT04664491 ·Status: RECRUITING ·Phase: NA
-
Budesonide / Formoterol in Treatment of Exacerbations of COPD
NCT00239278 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease
NCT02700919 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Formoterol/Fluticasone and Salmeterol/Fluticasone in Patients With Moderate-to-severe COPD
NCT01393145 ·Status: WITHDRAWN ·Phase: PHASE3
-
Efficacy of AZD3199 in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00929708 ·Status: COMPLETED ·Phase: PHASE2
-
Atorvastatin Effect on Reduction of COPD Exacerbations
NCT04789057 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Single-dose Study to Investigate the Effects of 4 Different Doses of Inhaled AZD8683 in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT01708057 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Assess the Safety and Tolerability of Once Daily Inhaled Doses of GSK573719 Made With Magnesium Stearate in Subjects With Chronic Obstructive Pulmonary Disease(COPD)for 7 Days
NCT00732472 ·Status: COMPLETED ·Phase: PHASE2
-
Tolerability/Safety and Efficacy of Inhaled AZD4818 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT00629239 ·Status: COMPLETED ·Phase: PHASE2
-
An Efficacy Study of GSK2269557 Added to Standard Care in Subjects With an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
NCT02294734 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate Efficacy and Safety of Tozorakimab Injections Compared With Placebo in Adult Participants With Symptomatic Chronic Obstructive Pulmonary Disease (COPD) With a History of COPD Exacerbations and Elevated Eosinophils
NCT06897748 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy, Pharmacokinetics (PK), Safety and Tolerability Study of Inhaled AZD8871
NCT02971293 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase IIa Study to Investigate the Efficacy and Safety of AZD7624 in Chronic Obstructive Pulmonary Disease (COPD) Patients While on Maintenance Therapy
NCT02238483 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Efficacy and Safety of GSK573719 Delivered Via a Novel Dry Powder Inhaler in Subjects With COPD
NCT01387230 ·Status: COMPLETED ·Phase: PHASE3
-
Compliance With Clinical Guidelines and Effect on Patient Outcome of Treatment of Hospitalised Exacerbations of COPD
NCT04237896 ·Status: UNKNOWN
-
Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)
NCT04701983 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Inhaled H057 in the Treatment of Acute Exacerbations of Bronchiectasis
NCT06958861 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
NCT02449018 ·Status: COMPLETED ·Phase: PHASE2
-
Optimising Azithromycin Prevention Treatment in COPD to Reduce Exacerbations
NCT05772013 ·Status: RECRUITING ·Phase: PHASE4
-
Safety, Tolerability and Pharmacokinetics of QAK423A in Healthy Volunteers and Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT01197287 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)
NCT04751487 ·Status: COMPLETED ·Phase: PHASE3
-
A Single-dose Study to Investigate the Effects of 3 Different Doses of Inhaled AZD2115 in COPD Patients
NCT01498081 ·Status: COMPLETED ·Phase: PHASE2